In IMT, some nanomaterials induce immunogenic death (ICD) of cancer cells, typically by releasing calretin (CRT), high-mobility group protein 1(HMGB1), and adenosine triphosphate (ATP) outside the cell, thereby recruiting immune cells for IMT. The gene discussed is HMGB1; the disease is cancer.